CASP3 and fibrosis: The results showed that the levels of cleaved caspase 3 increased significantly in fibrosis group and in rats treated with DAPT at a dose of 10 mg/kg, and it decreased markedly in rats given DAPT at a dose of 50 mg/kg (p<0.05, Figure S2).